versión imprimible

Cytokine-Based Cancer Immunotherapies Summit

Evvnt Promotion / evvnt
24.03.2021 - 25.03.2021  Virtual
Time: 08:00 to 17:00
Temas de la conferencia
This is the primary industry platform dedicated to providing you insight into the latest clinical results and stimulating discussions around
how to take cytokine-based immunotherapy combinations forward.

The renewed interest in the anti-tumor properties of cytokines has led to an increase in the number of clinical trials that explore the safety and efficacy of cytokine-based drugs, not only as single agents, but also in combination with other immunomodulatory drugs.
Organizador profesional (PCO)
Hanson Wade

Speakers: Ruth Ganss, Professor in Translational Cancer Research, Harry Perkins Institute of Medical Research, University of Western Australia, and more.

Información e inscripción:
Mr. Customer Services
Medicina General
Cuota del Congreso
Digital Conference Only - Drug Developer Pricing: USD 1999.00, Digital Conference Only - Service Provider Pricing: USD 2499.00, Digital Conference Only - Academic Pricing: USD 1799.00
Los participantes esperaban
1000 - 1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Helix - Forschung & Beratung WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAMREF - African Medical and Research FoundationÖsterreichische Gesellschaft für Public HealthEuropean Public Health Association (EUPHA)newTreeÖsterreichische Akademie der ÄrzteÄrzte der Welt